Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

著者: Geert D’Haens, Séverine Vermeire, Guy Lambrecht, Filip Baert, Peter Bossuyt, Benjamin Pariente, Anthony Buisson, Yoram Bouhnik, Jérôme Filippi, Janneke vander Woude, Philippe Van Hootegem, Jacques Moreau, Édouard Louis, Denis Franchimont, Martine De Vos, Fazia Mana, Laurent Peyrin‐Biroulet, Hédia Brixi, Matthieu Allez, Philip Caenepeel, Alexandre Aubourg, Bas Oldenburg, Marieke Pierik, Ann Gils, Sylvie Chevret, David Laharie, Patricia Détré, Marie-Jo Bertin, Sabrina Williams - Gastroenterology 2018 被引用: 299